RxDoctor Payments Data

Rita Stueder, APRN

Nurse Practitioner · Great Bend, KSNPI 1952376709

Payments from drug & device makers

$3,486in general payments, 2019–2025

Across 215 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$502
  • Johnson & Johnson$403
  • Amgen$362
  • Sun Pharmaceutical Industries Inc.$230
  • UCB, Inc.$205
  • plus $767 from 12 others

What the payments were for

  • Food & beverage$3,19692%
  • Education$2908%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,486 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

See all nurse practitioner providers in Kansas

Medicare billing

Part B allowed, 2024
$404,173
Medicare patients
1,658
Services billed
9,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab24$91,690
AkliefTrifarotene14$9,247
Clobetasol Propionate129$6,258
Tacrolimus53$5,393
Fluorouracil63$4,420
Metronidazole69$3,621
Ketoconazole120$1,786
CiclopiroxCiclopirox Olamine107$1,608
Triamcinolone Acetonide170$1,146
Clindamycin Phosphate35$996
Fluocinonide12$560
Mupirocin70$537
Doxycycline Hyclate35$536
Doxycycline Monohydrate22$470
Imiquimod15$460

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Galderma Laboratories, L.p.Aklief$50$9,24714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,326 nurse practitioner providers in Kansas.

Other nurse practitioner in Great Bend

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →